Picture of smart phone in human hand

World leading smartphone and mobile technology research at Strathclyde...

The Strathprints institutional repository is a digital archive of University of Strathclyde's Open Access research outputs. Strathprints provides access to thousands of Open Access research papers by University of Strathclyde researchers, including by Strathclyde researchers from the Department of Computer & Information Sciences involved in researching exciting new applications for mobile and smartphone technology. But the transformative application of mobile technologies is also the focus of research within disciplines as diverse as Electronic & Electrical Engineering, Marketing, Human Resource Management and Biomedical Enginering, among others.

Explore Strathclyde's Open Access research on smartphone technology now...

Pharmacotherapy to improve outcomes in infrainguinal bypass graft surgery : a review of current treatment strategies

Jackson, Andrew J. and Coats, Paul and Orr, Douglas J. and Teenan, R. Paul and Wadsworth, Roger M. (2010) Pharmacotherapy to improve outcomes in infrainguinal bypass graft surgery : a review of current treatment strategies. Annals of Vascular Surgery, 24 (4). pp. 562-572. ISSN 0890-5096

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

A total of 12,000 infrainguinal bypass grafts are performed annually in the United Kingdom, with outcomes suboptimal: 20% of above-knee vein grafts require intervention by 3 years. Transatlantic Inter-Society Consensus (TASC) guidelines exist on pharmacological management of peripheral vascular disease patients, however, little is recommended regarding optimum pharmacological management following revascularization to improve graft patency. The current recommendation is that all patients are on an antiplatelet agent following bypass grafting, the only intervention with significant evidence supporting use. This article will review pharmacological strategies aimed at improving the survival of infrainguinal vein grafts and the current evidence base for their use.